GlassScriptPhysician profile
Julie Kim
NPI 1851305049
$61,229.60
in general payments reported to CMS, 2019-2025
18 companies · $1,962 in 2025
The $1,962 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $19K · 2021: $7,290 · 2022: $12K · 2023: $5,499 · 2024: $598 · 2025: $1,962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,640 · Education: $1,500 · Travel and Lodging: $1,118 · Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,640.00 |
| Education | $1,500.00 |
| Travel and Lodging | $1,118.24 |
| Food and Beverage | $800.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $30,911.12 | 2019-2020 | |
| Medtronic, INC. | $14,836.28 | 2021-2025 | Signia, Endo Gia Ultra |
| Intuitive Surgical, INC. | $11,037.77 | 2022-2025 | Da Vinci Surgical System |
| Sanofi-Aventis U.S. LLC | $1,208.00 | 2019 | |
| Medical Device Business Services, INC. | $963.92 | 2019 | |
| Bolder Surgical, LLC | $675.00 | 2023 | Coolseal Generator |
| Cardinal Health 200 LLC | $575.00 | 2024 | |
| Amgen INC. | $266.25 | 2020-2023 | Prolia, Evenity |
| Novo Nordisk INC | $182.06 | 2019-2023 | Wegovy |
| Ethicon US, LLC | $145.43 | 2022-2023 | Echelon Endopath, Enseal X1, Harmonic |
| Kci USA, INC. | $104.97 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $95.75 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.45 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $66.68 | 2019-2020 | |
| Lilly USA, LLC | $22.95 | 2024 | Zepbound, Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Concordia Pharmaceuticals INC. | $20.84 | 2019 | |
| Dexcom, INC. | $13.05 | 2019 | |
| Merck Sharp & Dohme LLC | $12.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.